Fluor Corporation (FLR) Form 144: Proposed sale of restricted shares listed

Rhea-AI Filing Summary

Fluor Corporation filed a Form 144 reporting proposed sales of restricted common stock tied to prior equity awards. The filing lists awards dated 02/23/2017 (5,712 shares), 03/06/2023 (1,514 shares) and 03/06/2024 (14,096 shares) on the NYSE.

The Form 144 entry shows the filing date 03/10/2026 and identifies the securities as restricted stock issued by Fluor Corporation. The excerpt does not list counterparties, proceeds, or transactions completed in the past three months.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 13355 Noel Road Suite Suite 700 Dallas TX 75240	21322	1045170	146564673	03/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	02/23/2017	RESTRICTED STOCK	FLUOR CORPORATION			5712	02/23/2017	EQUITY AWARD
COMMON	03/06/2023	RESTRICTED STOCK	FLUOR CORPORATION			1514	03/06/2023	EQUITY AWARD
COMMON	03/06/2024	RESTRICTED STOCK	FLUOR CORPORATION			14096	03/06/2024	EQUITY AWARD

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the FLR Form 144 filing disclose?

The filing discloses proposed sales of restricted common stock for Fluor Corporation. It lists equity awards dated 02/23/2017 (5,712 shares), 03/06/2023 (1,514 shares) and 03/06/2024 (14,096 shares) with a filing date of 03/10/2026.

Which securities and award dates are listed in the Form 144 for FLR?

The Form 144 lists restricted common stock tied to equity awards dated 02/23/2017, 03/06/2023, and 03/06/2024. Each award shows the number of shares associated: 5,712; 1,514; and 14,096 respectively.

On which exchange is Fluor Corporation listed according to the filing?

The excerpt identifies the issuer's exchange as the NYSE. The Form 144 entry includes the filing date 03/10/2026 alongside the exchange designation and the listed restricted common stock awards.

Does the Form 144 excerpt show sales completed in the past three months?

The provided excerpt includes a header for "Securities Sold During The Past 3 Months" but contains no listed transactions in that section. The filing text shows the award dates and share counts without detailing recent completed sales.

How many shares in total are associated with the listed awards in this excerpt?

The excerpt lists three award line items totaling the stated counts: 5,712, 1,514, and 14,096 shares. The filing presents these award quantities explicitly; it does not aggregate them into a single total within the excerpt.